A PREVIOUSLY healthy 13-year-old girl had nausea, vomiting, fatigue, weakness, and a 1.13-kg weight loss over 1 week without fever or diarrhea. Menarche was at 12 years of age, and she had regular periods.
The patient was admitted to the hospital with a diagnosis of acute gastritis and dehydration. She was afebrile, normotensive, mildly dehydrated, and in no distress. Her sexual maturation was Tanner stage IV. Pelvic examination was deferred initially, and the remaining physical examination results were normal. Results of initial laboratory tests were normal except for a total serum calcium level of 14.1 mg/dL, an ionized calcium level of 7.46 mg/dL (reference range, 4.60-5.30 mg/dL), and a serum phosphorus concentration of 2.2 mg/dL. The urine calcium/creatinine ratio was elevated at 0.53 (reference range, 0.05-0.25), and the result of a pregnancy test was negative. A technetium Tc-99m sestamibi scan showed no evidence of parathyroid adenoma or ectopic parathyroid. A thyroid function test, electrocardiogram, and an abdominal radiograph were all normal. The patient responded well to therapy for symptomatic control of hypercalcemia (ie, intravenous fluids, potassium phosphate, furosemide, calcitonin, and pamidronate). The total serum calcium level fell to 9.6 mg/dL.
The patient's serum parathyroid hormone (intact) level was low (<10 pg/mL) when total calcium was 13.4 mg/dL. The parathyroid hormone–related protein level was elevated at 45.5 pg/mL (reference level, <12.9 pg/mL), and 1,25-dihydroxyvitamin D was slightly elevated at 110 pg/mL (reference range, 15-90 pg/mL). A right lower pelvic mass was found on pelvic examination. Pelvic ultrasound examination found a 15 × 10 × 10 cm solid/cystic mass involving the right ovary. A 15 × 12 × 12 cm (865 g) solid right adnexal mass was found on laparotomy (Figure 1). Frozen sections were highly suspicious for malignancy. The patient underwent a right salpingo-oophorectomy, pelvic and periaortic lymphadenectomy, omentectomy, multiple peritoneal biopsies, and a left ovarian biopsy. The pathologist reported stage IA small-cell carcinoma of the ovary (Figure 2), and specimens stained positive for parathyroid hormone–related protein (1.96 pmol per gram of tissue). All nodes, omentum, peritoneum, and pelvic fluid were negative for parathyroid hormone–related protein. The left ovarian biopsy revealed a benign stromal cortical nodule. The patient developed transient hypocalcemia postoperatively, which was corrected by calcium supplement for a brief period.
At follow-up 10 months later, the patient had completed 6 cycles of chemotherapy with paclitaxel, carboplatin, and oral etoposide without any evidence of recurrence. Serum calcium concentrations were followed as a tumor marker and remained at 8.9 to 9.4 mg/dL. Cancer antigen 125 and alkaline phosphatase levels were normal. Pelvic ultrasound examinations showed no recurrence.
At 13 months' follow-up, the patient had recurrence of hypercalcemia (serum calcium level, 11 mg/dL). A laparotomy showed recurrent small cell carcinoma involving the left ovary, left fallopian tube, rectosigmoid surface, bladder, peritoneum, and abdominal wall. The patient underwent a left salpingo-oophorectomy, hysterectomy, and tumor debulking with no residual tumor visible. She resumed chemotherapy with ifosfamide and topotecan hydrochloride without success. The patient died 36 months after the initial diagnosis.
Accepted for publication September 15, 1999.
We thank Edward C. Kohaut, MD, Nemours Children's Clinic, Pensacola, Fla, and Franklin Abbott, MD (Department of Radiology), William R. Bell, Jr, MD, and Everett Havard, MD (Department of Pathology), Sacred Heart Hospital, Pensacola, for their kind and expedient assistance.
Reprints: Helen Y. Hsiang, MD, 5153 N Ninth Ave, Pensacola, FL 32504 (e-mail: email@example.com).
Thank you for submitting a comment on this article. It will be reviewed by JAMA Pediatrics editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 4
Customize your page view by dragging & repositioning the boxes below.
Care at the Close of Life: Evidence and Experience
The Role of Chemotherapy at the End of Life: "When Is Enough, Enough?"
Care at the Close of Life: Evidence and Experience
Chemotherapy and Hormonal Therapy
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.